Showing results (4651-4660 of 5,590) with videos related to
Sort By:
Pageof 559
Theranostics|October 24, 2022
ERK inactivation enhances stemness of NSCLC cells via promoting Slug-mediated epithelial-to-mesenchymal transitionShurui Cai, Na Li, Xuetao Bai, et al.Theranostics|October 24, 2022
Synthesis, preclinical evaluation and radiation dosimetry of a dual targeting PET tracer [68Ga]Ga-FAPI-RGDJie Zang, Xuejun Wen, Rong Lin, et al.Theranostics|October 24, 2022
A novel afterglow nanoreporter for monitoring cancer therapyShiyi Liao, Youjuan Wang, Zhe Li, et al.Theranostics|October 24, 2022
A sporadic Alzheimer's blood-brain barrier model for developing ultrasound-mediated delivery of Aducanumab and anti-Tau antibodiesJoanna M Wasielewska, Juliana C S Chaves, Rebecca L Johnston, et al.Theranostics|October 24, 2022
Specificity of oligonucleotide gene therapy (OGT) agentsDaria D Nedorezova, Mikhail V Dubovichenko, Ekaterina P Belyaeva, et al.Theranostics|October 24, 2022
Advancing 89Zr-immuno-PET in neuroscience with a bispecific anti-amyloid-beta monoclonal antibody - The choice of chelator is essentialThomas E Wuensche, Natascha Stergiou, Iris Mes, et al.Theranostics|July 23, 2016
Dihydropyrimidine Dehydrogenase Is a Prognostic Marker for Mesenchymal Stem Cell-Mediated Cytosine Deaminase Gene and 5-Fluorocytosine Prodrug Therapy for the Treatment of Recurrent GliomasTaemoon Chung, Juri Na, Young-Il Kim, et al.Theranostics|July 23, 2016
Novel Cs-Based Upconversion Nanoparticles as Dual-Modal CT and UCL Imaging Agents for Chemo-Photothermal Synergistic TherapyYuxin Liu, Luoyuan Li, Quanwei Guo, et al.Theranostics|July 23, 2016
Cell-Specific Promoters Enable Lipid-Based Nanoparticles to Deliver Genes to Specific Cells of the Retina In VivoYuhong Wang, Ammaji Rajala, Binrui Cao, et al.Theranostics|July 23, 2016
Pharmacokinetic Behaviors of Intravenously Administered siRNA in Glandular TissuesYuanyu Huang, Qiang Cheng, Jia-Li Ji, et al.Pageof 559